| Primary |
| Atrial Fibrillation |
73.3% |
| Hypertension |
7.5% |
| Drug Use For Unknown Indication |
2.9% |
| Heart Rate |
2.3% |
| Product Used For Unknown Indication |
2.2% |
| Thrombosis |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Atrial Flutter |
1.1% |
| Heart Rate Abnormal |
1.0% |
| Coronary Artery Disease |
0.7% |
| Renal Failure Chronic |
0.7% |
| Ventricular Tachycardia |
0.7% |
| Gastric Disorder |
0.6% |
| Arrhythmia |
0.5% |
| Blood Pressure Abnormal |
0.5% |
| Cardiac Failure |
0.5% |
| Cervical Myelopathy |
0.5% |
| Osteoarthritis |
0.5% |
| Blood Pressure Management |
0.4% |
|
| Cardiac Failure |
37.4% |
| Cardiac Death |
8.0% |
| Ischaemic Stroke |
7.7% |
| Renal Failure Acute |
6.6% |
| Syncope |
6.4% |
| International Normalised Ratio Increased |
3.7% |
| Cardiac Failure Congestive |
3.2% |
| Angina Unstable |
2.9% |
| Atrial Fibrillation |
2.9% |
| Ventricular Tachycardia |
2.9% |
| Transient Ischaemic Attack |
2.7% |
| Bradycardia |
2.1% |
| Blood Creatinine Increased |
1.9% |
| Bradyarrhythmia |
1.9% |
| Dyspnoea |
1.9% |
| Death |
1.6% |
| Hepatic Enzyme Increased |
1.6% |
| Hypertension |
1.6% |
| Myocardial Infarction |
1.6% |
| Renal Failure |
1.6% |
|
| Secondary |
| Atrial Fibrillation |
51.3% |
| Product Used For Unknown Indication |
21.0% |
| Atrial Flutter |
6.7% |
| Arrhythmia |
3.4% |
| Hypertension |
3.4% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Blood Cholesterol Increased |
1.3% |
| Cardiac Failure |
1.3% |
| Myocardial Infarction |
1.3% |
| Anxiety |
0.8% |
| Cardioversion |
0.8% |
| Coronary Artery Disease |
0.8% |
| Glaucoma |
0.8% |
| Heart Rate Increased |
0.8% |
| Hypothyroidism |
0.8% |
| Pain |
0.8% |
| Pulmonary Arterial Hypertension |
0.8% |
| Tachycardia |
0.8% |
| Thrombosis Prophylaxis |
0.8% |
| Bipolar Disorder |
0.4% |
|
| Irritability |
7.6% |
| Myalgia |
7.6% |
| Pain In Extremity |
7.6% |
| Vomiting |
7.6% |
| Bradycardia |
6.3% |
| Dizziness |
6.3% |
| Palpitations |
6.3% |
| Hepatic Enzyme Increased |
5.1% |
| Pain |
5.1% |
| Swelling |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Cardiac Arrest |
3.8% |
| Drug Ineffective |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Syncope |
3.8% |
| Torsade De Pointes |
3.8% |
| Arrhythmia |
2.5% |
| Bladder Disorder |
2.5% |
| Confusional State |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.4% |
| Atrial Fibrillation |
16.9% |
| Drug Use For Unknown Indication |
16.9% |
| Hypertension |
4.8% |
| Cardiac Disorder |
3.1% |
| Hypercholesterolaemia |
2.8% |
| Gastrointestinal Pain |
2.4% |
| Heart Valve Incompetence |
2.1% |
| Multiple Myeloma |
2.1% |
| Myocardial Infarction |
2.1% |
| Cerebrovascular Accident Prophylaxis |
1.7% |
| Hypersensitivity |
1.7% |
| Insomnia |
1.7% |
| Osteoporosis |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Pain |
1.4% |
| Blood Cholesterol Increased |
1.0% |
| Discomfort |
1.0% |
| Prostate Cancer |
1.0% |
| Anticoagulant Therapy |
0.7% |
|
| Glomerular Filtration Rate Decreased |
17.9% |
| Renal Failure Acute |
12.8% |
| Rectal Haemorrhage |
7.7% |
| Sepsis |
7.7% |
| Viral Infection |
7.7% |
| Feeling Hot |
5.1% |
| Intestinal Perforation |
5.1% |
| Pulmonary Embolism |
5.1% |
| Abdominal Pain |
2.6% |
| Acute Prerenal Failure |
2.6% |
| Anaemia |
2.6% |
| Arrhythmia |
2.6% |
| Blood Thyroid Stimulating Hormone Decreased |
2.6% |
| Blood Urine Present |
2.6% |
| Cardiac Failure Chronic |
2.6% |
| Circulatory Collapse |
2.6% |
| Coagulopathy |
2.6% |
| Contusion |
2.6% |
| Cough |
2.6% |
| Dizziness |
2.6% |
|
| Interacting |
| Atrial Fibrillation |
61.9% |
| Diabetes Mellitus |
4.8% |
| Hypertension |
4.8% |
| Hypothyroidism |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Prostate Cancer |
4.8% |
| Prostate Cancer Metastatic |
4.8% |
| Respiratory Tract Infection |
4.8% |
| Urinary Tract Infection |
4.8% |
|
| Electrocardiogram Qt Prolonged |
15.4% |
| Diarrhoea |
7.7% |
| Drug Interaction |
7.7% |
| International Normalised Ratio Increased |
7.7% |
| No Adverse Event |
7.7% |
| Overdose |
7.7% |
| Palpitations |
7.7% |
| Presyncope |
7.7% |
| Skin Lesion |
7.7% |
| Syncope |
7.7% |
| Thinking Abnormal |
7.7% |
| Urinary Tract Infection |
7.7% |
|
